Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Carisma Therapeutics Inc CARM

Healthcare Biotechnology
Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing its proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. It is developing a pipeline of product candidates, with an initial focus on advancing multiple ex vivo autologous and in vivo CAR-M therapies for the... see more

Recent & Breaking News (NDAQ:CARM)

CLASS ACTION UPDATE for LIVE, SESN and SPPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire September 20, 2021

SESN INVESTOR LAWSUIT FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Sesen Bio, Inc.

Newsfile September 20, 2021

SHAREHOLDER ALERT: COIN YALA SESN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Accesswire September 20, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sesen Bio, Inc. of Class Action Lawsuit and Upcoming Deadline - SESN

PR Newswire September 19, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OTLY, AHCO and SESN

Accesswire September 19, 2021

Sesen Deadline Alert

Newsfile September 19, 2021

Lawsuits Filed Against VIEW, SESN and HNST - Jakubowitz Law Pursues Shareholders Claims

Accesswire September 17, 2021

Sesen Update

Newsfile September 17, 2021

SESN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 18, 2021 in the Class Action Filed on Behalf of Sesen Bio, Inc. Limited Shareholders

Newsfile September 17, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sesen Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - SESN

Newsfile September 17, 2021

Sesen Bio News: Berger Montague Investigates Securities Fraud Allegations Against Sesen Bio, Inc. (SESN); Lead Plaintiff Deadline is October 18, 2021

Newsfile September 17, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ATVI, VIEW and SESN

Accesswire September 17, 2021

CLASS ACTION UPDATE for VIEW, SESN and SAVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire September 17, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LIVE, SESN and HYRE

Accesswire September 17, 2021

Sesen Class Action Reminder

Newsfile September 16, 2021

Rosen, Globally Respected Investor Counsel, Encourages Sesen Bio, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - SESN

Newsfile September 16, 2021

Sesen Shareholder Notice

Newsfile September 15, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sesen Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - SESN

Newsfile September 15, 2021

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Sesen Bio (SESN) Investors of Application Deadline in Securities Class Action, Encourages Investors with Significant Losses to Contact Firm's Attorneys Now

Newsfile September 15, 2021

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Sesen Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - (SESN)

Newsfile September 15, 2021